{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:48:07Z","timestamp":1787032087419,"version":"build-2736575974"},"reference-count":36,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BST"],"published-print":{"date-parts":[[2018,4,30]]},"DOI":"10.5582\/bst.2018.01009","type":"journal-article","created":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T18:18:54Z","timestamp":1524075534000},"page":"168-176","source":"Crossref","is-referenced-by-count":41,"title":["Renal protective effect of Paeoniflorin by inhibition of JAK2\/STAT3 signaling pathway in diabetic mice"],"prefix":"10.5582","volume":"12","author":[{"given":"Xinyu","family":"Li","sequence":"first","affiliation":[{"name":"Department of Nephrology, the First Affiliated Hospital, Anhui Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, the First Affiliated Hospital, Anhui Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, the First Affiliated Hospital, Anhui Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonggui","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, the First Affiliated Hospital, Anhui Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Tuttle KR, Bakris GL, Bilous RW, Chiang JL, de Boer IH, Goldstein-Fuchs J, Hirsch IB, Kalantar-Zadeh K, Narva AS, Navaneethan SD, Neumiller JJ, Patel UD, Ratner RE, Whaley-Connell AT, Molitch ME. Diabetic kidney disease: A report from an ADA Consensus Conference. Am J Kidney Dis. 2014; 64:510-533.","DOI":"10.1053\/j.ajkd.2014.08.001"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Zhang L, Long J, Jiang W, Shi Y, He X, Zhou Z, Li Y, Yeung RO, Wang J, Matsushita K, Coresh J, Zhao MH, Wang H. Trends in chronic kidney disease in China. N Engl J Med. 2016; 375:905-906.","DOI":"10.1056\/NEJMc1602469"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kanwar YS, Sun L, Xie P, Liu FY, Chen S. A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annu Rev Pathol. 2011; 6:395-423.","DOI":"10.1146\/annurev.pathol.4.110807.092150"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Duran-Salgado MB, Rubio-Guerra AF. Diabetic nephropathy and inflammation. World J Diabetes. 2014; 5:393-398.","DOI":"10.4239\/wjd.v5.i3.393"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Fernandez-Fernandez B, Ortiz A, Gomez-Guerrero C, Egido J. Therapeutic approaches to diabetic nephropathy--beyond the RAS. Nat Rev Nephrol. 2014; 10:325-346.","DOI":"10.1038\/nrneph.2014.74"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Brosius FC 3rd, He JC. JAK inhibition and progressive kidney disease. Curr Opin Nephrol Hypertens. 2015; 24:88-95.","DOI":"10.1097\/MNH.0000000000000079"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Stark GR, Darnell JE Jr. The JAK-STAT pathway at twenty. Immunity. 2012; 36:503-514.","DOI":"10.1016\/j.immuni.2012.03.013"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Berthier CC, Zhang H, Schin M, Henger A, Nelson RG, Yee B, Boucherot A, Neusser MA, Cohen CD, Carter-Su C, Argetsinger LS, Rastaldi MP, Brosius FC, Kretzler M. Enhanced expression of Janus kinase-signal transducer and activator of transcription pathway members in human diabetic nephropathy. Diabetes. 2009; 58:469-477.","DOI":"10.2337\/db08-1328"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. He DY, Dai SM. Anti-inflammatory and immunomodulatory effects of paeonia lactiflora pall., a traditional chinese herbal medicine. Front Pharmacol. 2011; 2:10.","DOI":"10.3389\/fphar.2011.00010"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Liu HQ, Zhang WY, Luo XT, Ye Y, Zhu XZ. Paeoniflorin attenuates neuroinflammation and dopaminergic neurodegeneration in the MPTP model of Parkinson's disease by activation of adenosine A1 receptor. Br J Pharmacol. 2006; 148:314-325.","DOI":"10.1038\/sj.bjp.0706732"},{"key":"11","unstructured":"11. Ouyang J, Xu H, Li M, Dai X, Fu F, Zhang X, Lan Q. Paeoniflorin exerts antitumor effects by inactivating S phase kinase-associated protein 2 in glioma cells. Oncol Rep. 2018; 39:1052-1062."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Wang C, Yuan J, Wu HX, Chang Y, Wang QT, Wu YJ, Liu LH, Wei W. Paeoniflorin inhibits inflammatory responses in mice with allergic contact dermatitis by regulating the balance between inflammatory and anti-inflammatory cytokines. Inflamm Res. 2013; 62:1035-1044.","DOI":"10.1007\/s00011-013-0662-8"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Zhai T, Sun Y, Li H, Zhang J, Huo R, Li H, Shen B, Li N. Unique immunomodulatory effect of paeoniflorin on type I and II macrophages activities. J Pharmacol Sci. 2016; 130:143-150.","DOI":"10.1016\/j.jphs.2015.12.007"},{"key":"14","unstructured":"14. Fu J, Li Y, Wang L, Gao B, Zhang N, Ji Q. Paeoniflorin prevents diabetic nephropathy in rats. Comp Med. 2009; 59:557-566."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Zhang T, Zhu Q, Shao Y, Wang K, Wu Y. Paeoniflorin prevents TLR2\/4-mediated inflammation in type 2 diabetic nephropathy. Biosci Trends. 2017; 11:308-318.","DOI":"10.5582\/bst.2017.01104"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Breyer MD, Bottinger E, Brosius FC, 3rd, Coffman TM, Harris RC, Heilig CW, Sharma K. Mouse models of diabetic nephropathy. J Am Soc Nephrol. 2005; 16:27- 45.","DOI":"10.1681\/ASN.2004080648"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Zhang LL, Wei W, Wang NP, Wang QT, Chen JY, Chen Y, Wu H, Hu XY. Paeoniflorin suppresses inflammatory mediator production and regulates G protein-coupled signaling in fibroblast-like synoviocytes of collagen induced arthritic rats. Inflamm Res. 2008; 57:388-395.","DOI":"10.1007\/s00011-007-7240-x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Zhang H, Li P, Burczynski FJ, Gong Y, Choy P, Sha H, Li J. Attenuation of Diabetic Nephropathy in Otsuka Long-Evans Tokushima Fatty (OLETF) Rats with a Combination of Chinese Herbs (Tangshen Formula). Evid Based Complement Alternat Med. 2011; 2011:613737.","DOI":"10.1155\/2011\/613737"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001; 25:402-408.","DOI":"10.1006\/meth.2001.1262"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Bakris GL, Molitch M. Microalbuminuria as a risk predictor in diabetes: The continuing saga. Diabetes care. 2014; 37:867-875.","DOI":"10.2337\/dc13-1870"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Shuhong Z, Hongjun L, Bo C, Li X, Bingyin S. The effect of dantonic pill on beta -catenin expression in a rat model of streptozotocin-induced early stage of diabetic nephropathy. J Diabetes Res. 2013; 2013:848679.","DOI":"10.1155\/2013\/848679"},{"key":"22","unstructured":"22. Dalla Vestra M, Saller A, Mauer M, Fioretto P. Role of mesangial expansion in the pathogenesis of diabetic nephropathy. J Nephrol. 2001; 14 Suppl 4:S51-S57."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Xue R, Gui D, Zheng L, Zhai R, Wang F. Mechanistic insight and management of diabetic nephropathy: Recent progress and future perspective. J Diabetes Res. 2017; 2017:1839809.","DOI":"10.1155\/2017\/1839809"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Gu P, Zhu L, Liu Y, Zhang L, Liu J, Shen H. Protective effects of paeoniflorin on TNBS-induced ulcerative colitis through inhibiting NF-kappaB pathway and apoptosis in mice. Int Immunopharmacol. 2017; 50:152-160.","DOI":"10.1016\/j.intimp.2017.06.022"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Jia Z, He J. Paeoniflorin ameliorates rheumatoid arthritis in rat models through oxidative stress, inflammation and cyclooxygenase 2. Exp Ther Med. 2016; 11:655-659.","DOI":"10.3892\/etm.2015.2908"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Zhao Y, Ma X, Wang J, Zhu Y, Li R, Wang J, He X, Shan L, Wang R, Wang L, Li Y, Xiao X. Paeoniflorin alleviates liver fibrosis by inhibiting HIF-1alpha through mTOR dependent pathway. Fitoterapia. 2014; 99:318-327.","DOI":"10.1016\/j.fitote.2014.10.009"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Zeng J, Dou Y, Guo J, Wu X, Dai Y. Paeoniflorin of Paeonia lactiflora prevents renal interstitial fibrosis induced by unilateral ureteral obstruction in mice. Phytomedicine. 2013; 20:753-759.","DOI":"10.1016\/j.phymed.2013.02.010"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Wang P, Wang W, Shi Q, Zhao L, Mei F, Li C, Zuo T, He X.Paeoniflorin ameliorates acute necrotizing pancreatitis and pancreatitis induced acute renal injury. Mol Med Rep. 2016; 14:1123-1131.","DOI":"10.3892\/mmr.2016.5351"},{"key":"29","unstructured":"29. Ma J, Wu H, Zhao CY, Panchapakesan U, Pollock C, Chadban SJ. Requirement for TLR2 in the development of albuminuria, inflammation and fibrosis in experimental diabetic nephropathy. Int J Clin Exp Pathol. 2014; 7:481-495."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Meng XM, Tang PM, Li J, Lan HY. Macrophage Phenotype in Kidney Injury and Repair. Kidney Dis (Basel). 2015; 1:138-146.","DOI":"10.1159\/000431214"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Guiteras R, Flaquer M, Cruzado JM. Macrophage in chronic kidney disease. Clin Kidney J. 2016; 9:765-771.","DOI":"10.1093\/ckj\/sfw096"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Wu CC, Sytwu HK, Lin YF. Cytokines in diabetic nephropathy. Adv Clin Chem. 2012; 56:55-74.","DOI":"10.1016\/B978-0-12-394317-0.00014-5"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Brosius FC, Tuttle KR, Kretzler M. JAK inhibition in the treatment of diabetic kidney disease. Diabetologia. 2016; 59:1624-1627.","DOI":"10.1007\/s00125-016-4021-5"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Lacava V, Pellicano V, Ferrajolo C, Cernaro V, Visconti L, Conti G, Buemi M, Santoro D. Novel avenues for treating diabetic nephropathy: New investigational drugs. Expert Opin Investig Drugs. 2017; 26:445-462.","DOI":"10.1080\/13543784.2017.1293039"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Heerspink HJ, De Zeeuw D. Novel anti-inflammatory drugs for the treatment of diabetic kidney disease. Diabetologia. 2016; 59:1621-1623.","DOI":"10.1007\/s00125-016-4030-4"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Zhou D, Huang C, Lin Z, Zhan S, Kong L, Fang C, Li J. Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signaling pathways. Cell Signal. 2014; 26:192-197.","DOI":"10.1016\/j.cellsig.2013.11.004"}],"container-title":["BioScience Trends"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/12\/2\/12_2018.01009\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T06:03:52Z","timestamp":1526882632000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/12\/2\/12_2018.01009\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,30]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.5582\/bst.2018.01009","relation":{},"ISSN":["1881-7815","1881-7823"],"issn-type":[{"value":"1881-7815","type":"print"},{"value":"1881-7823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,30]]}}}